Cargando…

Evidence for Cognitive Decline in Chronic Pain: A Systematic Review and Meta-Analysis

Background: People with chronic pain (CP) sometimes report impaired cognitive function, including a deficit of attention, memory, executive planning, and information processing. However, the association between CP and cognitive decline was still not clear. Our study aimed to assess the association o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xueying, Gao, Rui, Zhang, Changteng, Chen, Hai, Wang, Ruiqun, Zhao, Qi, Zhu, Tao, Chen, Chan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492915/
https://www.ncbi.nlm.nih.gov/pubmed/34630023
http://dx.doi.org/10.3389/fnins.2021.737874
_version_ 1784579014729400320
author Zhang, Xueying
Gao, Rui
Zhang, Changteng
Chen, Hai
Wang, Ruiqun
Zhao, Qi
Zhu, Tao
Chen, Chan
author_facet Zhang, Xueying
Gao, Rui
Zhang, Changteng
Chen, Hai
Wang, Ruiqun
Zhao, Qi
Zhu, Tao
Chen, Chan
author_sort Zhang, Xueying
collection PubMed
description Background: People with chronic pain (CP) sometimes report impaired cognitive function, including a deficit of attention, memory, executive planning, and information processing. However, the association between CP and cognitive decline was still not clear. Our study aimed to assess the association of CP as a risk factor with cognitive decline among adults. Methods: We included data from clinical studies. Publications were identified using a systematic search strategy from PubMed, Embase, and Cochrane Library databases from inception to October 10, 2020. We used the mean cognitive outcome data and the standard deviations from each group. The standardized mean difference (SMD) or odds ratio (OR), and 95% confidence intervals (CI) were performed for each cognitive decline outcome. I(2)-values were assessed to quantify the heterogeneities. Results: We included 37 studies with a total of 52,373 patients with CP and 80,434 healthy control participants. Because these studies used different evaluative methods, we analyzed these studies. The results showed CP was associated with cognitive decline when the short-form 36 health survey questionnaire (SF-36) mental component summary (SMD = −1.50, 95% CI = −2.19 to −0.81), the Montreal cognitive assessment (SMD = −1.11, 95% CI = −1.60 to −0.61), performance validity testing (SMD = 3.05, 95% CI = 1.74 to 4.37), or operation span (SMD = −1.83, 95% CI = −2.98 to −0.68) were used. However, we got opposite results when the studies using International Classification of Diseases and Related Health Problems classification (OR = 1.58, 95% CI = 0.97 to 2.56), the Mini-Mental State Examination (SMD = −0.42, 95% CI = −0.94 to 0.10; OR = 1.14, 95% CI = 0.91 to 1.42), and Repeatable Battery for the Assessment of Neuropsychological Status memory component (SMD = −0.06, 95% CI = −0.37 to 0.25). Conclusion: There may be an association between CP and the incidence of cognitive decline when some cognitive, evaluative methods were used, such as short-form 36 health survey questionnaire, Montreal cognitive assessment, performance validity testing, and operation span.
format Online
Article
Text
id pubmed-8492915
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84929152021-10-07 Evidence for Cognitive Decline in Chronic Pain: A Systematic Review and Meta-Analysis Zhang, Xueying Gao, Rui Zhang, Changteng Chen, Hai Wang, Ruiqun Zhao, Qi Zhu, Tao Chen, Chan Front Neurosci Neuroscience Background: People with chronic pain (CP) sometimes report impaired cognitive function, including a deficit of attention, memory, executive planning, and information processing. However, the association between CP and cognitive decline was still not clear. Our study aimed to assess the association of CP as a risk factor with cognitive decline among adults. Methods: We included data from clinical studies. Publications were identified using a systematic search strategy from PubMed, Embase, and Cochrane Library databases from inception to October 10, 2020. We used the mean cognitive outcome data and the standard deviations from each group. The standardized mean difference (SMD) or odds ratio (OR), and 95% confidence intervals (CI) were performed for each cognitive decline outcome. I(2)-values were assessed to quantify the heterogeneities. Results: We included 37 studies with a total of 52,373 patients with CP and 80,434 healthy control participants. Because these studies used different evaluative methods, we analyzed these studies. The results showed CP was associated with cognitive decline when the short-form 36 health survey questionnaire (SF-36) mental component summary (SMD = −1.50, 95% CI = −2.19 to −0.81), the Montreal cognitive assessment (SMD = −1.11, 95% CI = −1.60 to −0.61), performance validity testing (SMD = 3.05, 95% CI = 1.74 to 4.37), or operation span (SMD = −1.83, 95% CI = −2.98 to −0.68) were used. However, we got opposite results when the studies using International Classification of Diseases and Related Health Problems classification (OR = 1.58, 95% CI = 0.97 to 2.56), the Mini-Mental State Examination (SMD = −0.42, 95% CI = −0.94 to 0.10; OR = 1.14, 95% CI = 0.91 to 1.42), and Repeatable Battery for the Assessment of Neuropsychological Status memory component (SMD = −0.06, 95% CI = −0.37 to 0.25). Conclusion: There may be an association between CP and the incidence of cognitive decline when some cognitive, evaluative methods were used, such as short-form 36 health survey questionnaire, Montreal cognitive assessment, performance validity testing, and operation span. Frontiers Media S.A. 2021-09-22 /pmc/articles/PMC8492915/ /pubmed/34630023 http://dx.doi.org/10.3389/fnins.2021.737874 Text en Copyright © 2021 Zhang, Gao, Zhang, Chen, Wang, Zhao, Zhu and Chen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Zhang, Xueying
Gao, Rui
Zhang, Changteng
Chen, Hai
Wang, Ruiqun
Zhao, Qi
Zhu, Tao
Chen, Chan
Evidence for Cognitive Decline in Chronic Pain: A Systematic Review and Meta-Analysis
title Evidence for Cognitive Decline in Chronic Pain: A Systematic Review and Meta-Analysis
title_full Evidence for Cognitive Decline in Chronic Pain: A Systematic Review and Meta-Analysis
title_fullStr Evidence for Cognitive Decline in Chronic Pain: A Systematic Review and Meta-Analysis
title_full_unstemmed Evidence for Cognitive Decline in Chronic Pain: A Systematic Review and Meta-Analysis
title_short Evidence for Cognitive Decline in Chronic Pain: A Systematic Review and Meta-Analysis
title_sort evidence for cognitive decline in chronic pain: a systematic review and meta-analysis
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492915/
https://www.ncbi.nlm.nih.gov/pubmed/34630023
http://dx.doi.org/10.3389/fnins.2021.737874
work_keys_str_mv AT zhangxueying evidenceforcognitivedeclineinchronicpainasystematicreviewandmetaanalysis
AT gaorui evidenceforcognitivedeclineinchronicpainasystematicreviewandmetaanalysis
AT zhangchangteng evidenceforcognitivedeclineinchronicpainasystematicreviewandmetaanalysis
AT chenhai evidenceforcognitivedeclineinchronicpainasystematicreviewandmetaanalysis
AT wangruiqun evidenceforcognitivedeclineinchronicpainasystematicreviewandmetaanalysis
AT zhaoqi evidenceforcognitivedeclineinchronicpainasystematicreviewandmetaanalysis
AT zhutao evidenceforcognitivedeclineinchronicpainasystematicreviewandmetaanalysis
AT chenchan evidenceforcognitivedeclineinchronicpainasystematicreviewandmetaanalysis